MoneyWorks4Me

Sequent Scientific - Quaterly Results

06 Nov 2023 Evaluate
The sales is pegged at Rs. 491.19 millions for the September 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 542.31 millions during the year-ago period.The Net Loss for the quarter ended September 2023 is Rs. -9.18 millions as compared to Net Loss of Rs. -40.50 millions of corresponding quarter ended September 2022 Operating profit Margin for the quarter ended September 2023 improved to 21.66% as compared to -28.53% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 491.19 542.31 -9.43 895.42 1190.91 -24.81 2226.85 2196.26 1.39
Other Income 98.66 67.26 46.68 195.61 126.06 55.17 282.42 276.43 2.17
PBIDT 21.66 -28.53 -175.92 27.94 10.37 169.43 18.82 268.93 -93.00
Interest 12.09 5.75 110.26 21.91 9.29 135.84 25.13 16.10 56.09
PBDT 9.57 -34.28 -127.92 -56.51 1.08 -5332.41 -6.31 252.83 -102.50
Depreciation 23.53 22.49 4.62 47.78 46.30 3.20 91.15 95.93 -4.98
PBT -13.96 -56.77 -75.41 -104.29 -45.22 130.63 -97.46 156.90 -162.12
TAX -4.78 -16.27 -70.62 -27.08 -13.12 106.40 -36.66 8.91 -511.45
Deferred Tax -19.80 -1.90 942.11 -27.08 -0.85 3085.88 -30.94 5.20 -695.00
PAT -9.18 -40.50 -77.33 -77.21 -32.10 140.53 -60.80 147.99 -141.08
Equity 498.86 498.86 0.00 498.87 498.87 0.00 498.87 496.74 0.43
PBIDTM(%) 4.41 -5.26 -183.82 3.12 0.87 258.33 0.85 12.24 -93.10
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1210.45
Cipla 1366.80
Lupin 2119.40
Zydus Lifesciences 1167.20
View more..